AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Acute Lymphoblastic Leukemia (ALL) Market Spotlight 2019 Featuring Fate Therapeutics, Novartis, Ono Pharmaceutical - ResearchAndMarkets.com

December 3, 2019

DUBLIN--(BUSINESS WIRE)--Dec 3, 2019--

The “Market Spotlight: Acute Lymphoblastic Leukemia (ALL)” report has been added to ResearchAndMarkets.com’s offering.

This Market Spotlight report covers the Acute Lymphoblastic Leukemia (ALL) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, regulatory events, probability of success, patent information, a 10-year disease incidence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

Key Takeaways

Key Topics Covered:

1. Overview

2. Key Takeaways

3. Disease Background

4. Treatment

5. Epidemiology

6. Marketed Drugs

7. Pipeline Drugs

8. Recent Events and Analyst Opinion

9. Key Upcoming Events

10. Key Regulatory Events

11. Probability of Success

12. Licensing and Asset Acquisition Deals

13. Parent Patents

14. Revenue Opportunity

15. Clinical Trial Landscape

16. Bibliography

17. Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/b9bd22

View source version on businesswire.com:https://www.businesswire.com/news/home/20191203006054/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/03/2019 04:47 PM/DISC: 12/03/2019 04:47 PM

http://www.businesswire.com/news/home/20191203006054/en